MSN, Neurology Live highlight UC Parkinson's trial results
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
The trial, led by UC's Alberto Espay, MD, found that 24-hour, continuous levodopa delivered through a subcutaneous infusion pump led to nearly two additional hours per day of "on time," or the time when the medication is working and symptoms are lessened, compared to taking levodopa orally.
“Levodopa is a replacement strategy. We all make levodopa, but Parkinson's patients make less of it,” said Espay, co-principal investigator of the trial, James J. and Joan A. Gardner Family Center for Parkinson’s Disease Research Endowed Chair in UC’s Department of Neurology and Rehabilitation Medicine and a physician at the UC Gardner Neuroscience Institute.
“Once approved, this will become an important treatment strategy to consider for patients with Parkinson’s disease experiencing motor fluctuations not adequately controlled with medication,” Espay continued. “Future studies will need to determine the durability of the long-term benefits and whether any safety issues could emerge, as well as how it might compare with deep brain stimulation.”
Read the MSN story, originally published on News Medical.
Read the Neurology Live story.
Healio, Physicians Weekly, Parkinson's News Today and Cleveland.com also covered the research.
Read the Parkinson's News Today article.
Read the Physicians Weekly article, originally published on Health Day.
Featured photo at top of 3-D illustration of a dopamine molecule. Photo/Dr_Microbe/iStock.
Related Stories
UC marks 4 years saving lives with mobile stroke unit
August 15, 2024
The University of Cincinnati's Christopher Richards spoke with Local 12 about the four-year anniversary of the mobile stroke unit that can bring the emergency department directly to patients.
Trial finds new drug safe, effective to treat deadliest form of epilepsy
October 23, 2024
MSN highlighted research presented by the University of Cincinnati’s Brandon Foreman that found ganaxolone is a safe and effective treatment for refractory status epilepticus.
Jacksonville media: New stroke research aims to help predict recovery
April 18, 2023
Jacksonville, Florida television news station WJXT highlighted the VERIFY study being led by University of Cincinnati researchers that will examine if certain biomarkers can predict the likelihood that a patient will recover motor functions following a stroke.